Tag: bioequivalence

Improving patient confidence in generics: research-based strategies

This article explores research-backed strategies to enhance patient confidence in generic medications, addressing common myths, communication tactics, and statistical evidence regarding safety and efficacy.

Combination NTI Drugs and Generic Availability: Coverage and Gaps

Combination NTI drugs-medications with narrow therapeutic windows-pose serious risks when switched to generics. With no approved generic combinations in the U.S., patients face higher costs, dangerous variability, and preventable adverse events.